CCN2 and cancer: Cancer-associated mucins, especially those expressed at the cell surface, imped the cellular clearance of low-sialylated cellular proteins, deregulate the expression of immune activation markers, induce the secretion of VEGF, CTGF, metastatic markers, and inhibit cytotoxic lymphocytes [171,172,178,179].